ARx Sublingual Thin Films offer rapid onset that rivals injections
With formulation knowledge and flexibility, ARx provides rapid drug delivery with Sublingual Thin Film formulations, where therapeutic effect can be noted within minutes. For lower dose, small molecules, sublingual films can even be a viable alternative to an injection. Excipients are carefully selected from ARx’s proprietary process to enhance the permeability of the drug substance, while offering a pleasant experience for the patient. Dissolvable films integrate most available forms of active pharmaceutical ingredients (APIs), including micronized, granulated, salt, and free-base forms. Both soluble and insoluble drugs have been successfully compounded into solutions and suspensions which are further processed into a dissolvable film. The intended dose is achieved by determining and precisely controlling the size and thickness of the final film.
Benefits of ARx sublingual thin film delivery systems for your drug, your patient, and your brand:
| Your Drug | Your Patient | Your Brand |
|---|---|---|
| Improved Tmax compared to tablet and capsules | Rapid therapeutic onset and relief | Market success through enhanced patient compliance |
| Tailored drug release or dissolution in a specific fluid or pH | Comfortable and discreet during dosing | Novel dosage form through produce line extension |
| GRAS excipients utilized to reduce regulatory risk | Eliminates the need to swallow medication | Customized size, shape, thickness, and color for brand recognition |
| Optimal stability and API compatibility with single or multi-layer systems | Easy to transport and administer | Individually pouched units offer additional space for printing logos and brand names |